List of Working Groups

Return

1.3 Early Warning Systems
1.4 Indicators of problematic drug use
1.5 National report
1.6 New threats
2.1.1.1 Validation of basic quality and evidence-based criteria for treatment and harm reduction programmes
2.1.1.2 Validation of advanced quality and evidence-based criteria for treatment and harm reduction programmes
3.5.2.1 Adaptation and translation of protocols ans guidelines for precursors control
3.5.2.2. Impulse to legislation for precursors control
4.2. EU-CELAC meeting point: new outcome document HLM EU-CELAC Mechanism on drugs